Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00757822 · ClinicalTrials.gov registry record · NA

Prevention of Postoperative Nausea and Vomiting (PONV) in Surgical Patients

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
216
Enrollment target

NCT00757822: Completed NA study, sponsored by VA Office of Research and Development.

NCT00757822 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 216 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00757822, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
216 participants
Enrollment target

Study Summary

This study will compare two different drug regimens (oral dronabinol versus intravenous ondanseteron) for the prevention of post-operative nausea and vomiting (PONV).

Primary Outcome

The incidence of postoperative nausea (PON) and postoperative vomiting (POV) was assessed during Post-operative Care Unit (PACU) stay.

Interventions

  • DRUG Ondansetron
  • DRUG Dronabinol

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2009-12
Est. Completion 2015-04
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT00757822 record still lists

NCT00757822 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which Ondansetron is the first listed.

NCT00757822 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00757822 about?

NCT00757822 is a clinical study titled "Prevention of Postoperative Nausea and Vomiting (PONV) in Surgical Patients". This study will compare two different drug regimens (oral dronabinol versus intravenous ondanseteron) for the prevention of post-operative nausea and vomiting (PONV).

What is the current status of trial NCT00757822?

This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2009-12. Estimated completion is 2015-04.

What interventions are being tested in trial NCT00757822?

The interventions under investigation include: Ondansetron (DRUG), Dronabinol (DRUG).

Who is sponsoring clinical trial NCT00757822?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00757822's enrollment target sits among peer trials

216 485th of 2000 higher than 1,514 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02609685 · 216 participants · NA

    Active Surveillance of Papillary Thyroid Microcarcinoma

  • NCT04994873 · 216 participants · NA

    Skills to Enhance Positivity in Suicidal Youth

  • NCT05264779 · 216 participants · NA

    The Periviable GOALS Decision Support Tool

  • NCT05434130 · 216 participants · Phase 2

    Modulating Exercise Dosage to Improve Concussion Recovery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00757822, the US trial registry maintained by the National Library of Medicine. NCT00757822 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.